28187742|t|Regulatory role of cytosolic phospholipase A2 alpha in the induction of CD40 in microglia
28187742|a|The aberrant expression of CD40, a co-stimulatory receptor found on the antigen-presenting cells, is involved in the pathogenesis of various degenerative diseases. Our previous study demonstrated that the reduction of cytosolic phospholipase A2 alpha (cPLA2α) protein overexpression and activation in the spinal cord of a mouse model of ALS, hmSOD1 G93A, inhibited CD40 upregulation in microglia. The present study was designed to determine whether cPLA2α has a direct, participatory role in the molecular events leading to CD40 induction. Cultures of primary mouse microglia or BV-2 microglia cell line exposed to lipopolysaccharide (LPS) or interferon gamma (IFNγ) for different periods of time, in order to study the role of cPLA2α in the events leading to CD40 protein induction. Addition of LPS or IFNγ caused a significant upregulation of cPLA2α and of CD40, while prevention of cPLA2α upregulation by a specific oligonucleotide antisense (AS) prevented the induction of CD40, suggesting a role of cPLA2α in the induction of CD40. Addition of LPS to microglia caused an immediate activation of cPLA2α detected by its phosphorylated form, while addition of IFNγ induced cPLA2α activation at a later time scale (4 h). The activation of cPLA2α is mediated by ERK activity. Suppression of cPLA2α activity inhibited superoxide production by NOX2-NADPH oxidase and activation of NF-κB detected by the phosphorylation of p65 on serine 536 at 15 min by LPS and at 4 h by IFNγ. Inhibition of NOX2 prevented NF-κB activation and CD40 induction but did not affect cPLA2α activation, suggesting cPLA2α is located upstream to NOX2 and NF-κB. The activation of cPLA2 by LPS was mediated by both adaptor proteins downstream to LPS receptor; TRIF and MyD88, while the activation of cPLA2α by IFNγ was mediated by the secreted TNF-α at 4 h. The early activation of STAT1α (detected by phospho-serine727 and phoshpo-tyrosine701) by IFNγ and the late activation of STAT1α by LPS were not affected in the presence of cPLA2α inhibitors, indicating that STAT1α is not under cPLA2α regulation. Our results show for the first time that cPLA2 upregulates CD40 protein expression induced by either LPS or IFNγ, and this regulatory effect is mediated via the activation of NOX2-NADPH oxidase and NF-κB. Cumulatively, our results indicate that cPLA2α may serve as a pivotal amplifier of the inflammatory response in the CNS.
28187742	0	15	Regulatory role	T038	UMLS:C1327622
28187742	19	51	cytosolic phospholipase A2 alpha	T103	UMLS:C1744635
28187742	72	76	CD40	T103	UMLS:C0054959
28187742	80	89	microglia	T017	UMLS:C0206116
28187742	117	121	CD40	T103	UMLS:C0054959
28187742	140	148	receptor	T103	UMLS:C0597357
28187742	162	186	antigen-presenting cells	T017	UMLS:C0003315
28187742	207	219	pathogenesis	T038	UMLS:C0699748
28187742	231	252	degenerative diseases	T038	UMLS:C1285162
28187742	308	340	cytosolic phospholipase A2 alpha	T103	UMLS:C1744635
28187742	342	348	cPLA2α	T103	UMLS:C1744635
28187742	350	372	protein overexpression	T038	UMLS:C1514559
28187742	395	406	spinal cord	T017	UMLS:C0037925
28187742	412	423	mouse model	T038	UMLS:C2986594
28187742	427	430	ALS	T038	UMLS:C0002736
28187742	432	443	hmSOD1 G93A	T103	UMLS:C0668601
28187742	445	454	inhibited	T038	UMLS:C0021469
28187742	455	459	CD40	T103	UMLS:C0054959
28187742	460	472	upregulation	T038	UMLS:C0949479
28187742	476	485	microglia	T017	UMLS:C0206116
28187742	539	545	cPLA2α	T103	UMLS:C1744635
28187742	614	618	CD40	T103	UMLS:C0054959
28187742	630	638	Cultures	T058	UMLS:C1449562
28187742	650	655	mouse	T204	UMLS:C0026809
28187742	656	665	microglia	T017	UMLS:C0206116
28187742	669	693	BV-2 microglia cell line	T017	UMLS:C0007600
28187742	705	723	lipopolysaccharide	T103	UMLS:C0023810
28187742	725	728	LPS	T103	UMLS:C0023810
28187742	733	749	interferon gamma	T103	UMLS:C3539881
28187742	751	755	IFNγ	T103	UMLS:C3539881
28187742	818	824	cPLA2α	T103	UMLS:C1744635
28187742	850	854	CD40	T103	UMLS:C0054959
28187742	855	862	protein	T103	UMLS:C0033684
28187742	886	889	LPS	T103	UMLS:C0023810
28187742	893	897	IFNγ	T103	UMLS:C3539881
28187742	919	931	upregulation	T038	UMLS:C0041904
28187742	935	941	cPLA2α	T103	UMLS:C1744635
28187742	949	953	CD40	T103	UMLS:C0054959
28187742	975	981	cPLA2α	T103	UMLS:C1744635
28187742	982	994	upregulation	T038	UMLS:C0041904
28187742	1009	1034	oligonucleotide antisense	T103	UMLS:C0079925
28187742	1036	1038	AS	T103	UMLS:C0079925
28187742	1067	1071	CD40	T103	UMLS:C0054959
28187742	1094	1100	cPLA2α	T103	UMLS:C1744635
28187742	1121	1125	CD40	T103	UMLS:C0054959
28187742	1139	1142	LPS	T103	UMLS:C0023810
28187742	1146	1155	microglia	T017	UMLS:C0206116
28187742	1190	1196	cPLA2α	T103	UMLS:C1744635
28187742	1213	1227	phosphorylated	T038	UMLS:C1158886
28187742	1252	1256	IFNγ	T103	UMLS:C3539881
28187742	1265	1271	cPLA2α	T103	UMLS:C1744635
28187742	1330	1336	cPLA2α	T103	UMLS:C1744635
28187742	1352	1364	ERK activity	T038	UMLS:C2261601
28187742	1381	1387	cPLA2α	T103	UMLS:C1744635
28187742	1407	1450	superoxide production by NOX2-NADPH oxidase	T103	UMLS:C0897757
28187742	1455	1465	activation	T038	UMLS:C1512670
28187742	1469	1474	NF-κB	T103	UMLS:C0079904
28187742	1491	1506	phosphorylation	T038	UMLS:C0031715
28187742	1517	1527	serine 536	T103	UMLS:C0036720
28187742	1541	1544	LPS	T103	UMLS:C0023810
28187742	1559	1563	IFNγ	T103	UMLS:C3539881
28187742	1565	1575	Inhibition	T038	UMLS:C1524081
28187742	1579	1583	NOX2	T103	UMLS:C0068355
28187742	1594	1599	NF-κB	T103	UMLS:C0079904
28187742	1600	1610	activation	T038	UMLS:C1512670
28187742	1615	1619	CD40	T103	UMLS:C0054959
28187742	1649	1655	cPLA2α	T103	UMLS:C1744635
28187742	1679	1685	cPLA2α	T103	UMLS:C1744635
28187742	1697	1705	upstream	T082	UMLS:C0522505
28187742	1709	1713	NOX2	T103	UMLS:C0068355
28187742	1718	1723	NF-κB	T103	UMLS:C0079904
28187742	1743	1748	cPLA2	T103	UMLS:C1744635
28187742	1752	1755	LPS	T103	UMLS:C0023810
28187742	1777	1793	adaptor proteins	T103	UMLS:C1449886
28187742	1794	1804	downstream	T082	UMLS:C0522506
28187742	1808	1820	LPS receptor	T103	UMLS:C0108768
28187742	1822	1826	TRIF	T038	UMLS:C3158853
28187742	1831	1836	MyD88	T038	UMLS:C1819764
28187742	1862	1868	cPLA2α	T103	UMLS:C1744635
28187742	1872	1876	IFNγ	T103	UMLS:C3539881
28187742	1897	1905	secreted	T038	UMLS:C0036536
28187742	1906	1911	TNF-α	T103	UMLS:C1456820
28187742	1944	1950	STAT1α	T103	UMLS:C0379862
28187742	1964	1981	phospho-serine727	T103	UMLS:C0031721
28187742	1986	2005	phoshpo-tyrosine701	T103	UMLS:C0070948
28187742	2010	2014	IFNγ	T103	UMLS:C3539881
28187742	2042	2048	STAT1α	T103	UMLS:C0379862
28187742	2052	2055	LPS	T103	UMLS:C0023810
28187742	2093	2099	cPLA2α	T103	UMLS:C1744635
28187742	2100	2110	inhibitors	T103	UMLS:C0033671
28187742	2128	2134	STAT1α	T103	UMLS:C0379862
28187742	2148	2154	cPLA2α	T103	UMLS:C1744635
28187742	2155	2165	regulation	T038	UMLS:C1522756
28187742	2208	2213	cPLA2	T103	UMLS:C1744635
28187742	2214	2225	upregulates	T038	UMLS:C0041904
28187742	2226	2230	CD40	T103	UMLS:C0054959
28187742	2231	2249	protein expression	T038	UMLS:C1171362
28187742	2268	2271	LPS	T103	UMLS:C0023810
28187742	2275	2279	IFNγ	T103	UMLS:C3539881
28187742	2290	2300	regulatory	T038	UMLS:C1327622
28187742	2328	2338	activation	T038	UMLS:C0014429
28187742	2342	2360	NOX2-NADPH oxidase	T103	UMLS:C0068355
28187742	2365	2370	NF-κB	T103	UMLS:C0079904
28187742	2412	2418	cPLA2α	T103	UMLS:C1744635
28187742	2459	2480	inflammatory response	T038	UMLS:C1155266
28187742	2488	2491	CNS	T022	UMLS:C3714787